This is the second asset Menarini Group has inlicensed from Insilico Medicine which was discovered through their generative AI platform,…
BOULDER, Colo., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Foresight Diagnostics, a leader in ultra-sensitive minimal residual disease (MRD) detection technology,…
-- Additional data from BROADWAY, BROOKLYN, and TANDEM to be presented throughout 2025; expected to support global regulatory filings for…
NEW YORK, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical…
Partnership seeks to improve patient outcomes and experience through novel digital and diagnostic solutions.Investment aligns with Danaher's mission to accelerate…
LAS VEGAS, Jan. 9, 2025 /PRNewswire/ -- AI Wellness (Assisted Intelligence Wellness) is taking center stage at CES 2025 with Mission…
HALIFAX, NS / ACCESSWIRE / January 9, 2025 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announced that its received investigational testing…
Partnership could allow up to 35 million1 women in the menopause transition to connect with comprehensive access to specialized healthcare through innovative at-home testing…
Arjan van Manen joins BioLizard as Commercial Director, bringing over 20 years of commercial leadership experience in life sciencesMeet BioLizard’s…
Appointment adds business, market and partner development expertise to FYR board Addition highlights FYR’s evolution into partner of choice for…